RIP kinase inhibitor RIPA-56, Purity ≥98%

Cat. No.: X23-10-ZQ170

RIP kinase inhibitor RIPA-56, Purity ≥98%

Synonym: 1956370-21-0; RIPA-56; N-Benzyl-N-hydroxy-2,2-dimethylbutanamide; RIP kinase inhibitor

  • MDL: MFCD30738006
  • CAS Number: 1956370-21-0
  • Compound CID: 121439991
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
RIPA-56, soluble in DMSO and ethanol and insoluble in water, is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.
Molecular Weight
221.3
Molecular Formula
C13H19NO2
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 38 mg/mL (171.71 mM); Water: Insoluble; Ethanol: 38 mg/mL (171.71 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
RIPA-56 can be used to investigate the inhibition of RIPK1 and its potential therapeutic applications.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.